Leah Sera, PharmD, MA, BCPS, associate professor of pharmacy practice and science, University of Maryland, shares the details and her role as the Program Director of the University’s Master’s program in Medical Cannabis. She details how cannabis can be used as a medicine to treat conditions such as pain, nausea, and muscle spasms, and she
Chadi sits down with a survivor of ovarian and breast cancer as well as her physician — a key advocate for a survivorship program at Advocate Healthcare System. The trio discuss the fault in the term “survivor” and why many patients reject this label, training that physicians need to better counsel patients on survivorship and
Jack West, MD, City of Hope Comprehensive Cancer Center, and Nathan Pennell, MD, PhD, Cleveland Clinic, debate the results of the ADAURA trial presented as a plenary session at the 2020 ASCO virtual meeting, especially the extrapolation from DFS to OS, balance of chemotherapy administration in the treatment arms, lumping of varying disease stages in
Mikkael Sekeres, MD, MS, director of the leukemia program, Cleveland Clinic, and esteemed author, essayist, and op-ed writer, discusses his latest work “When Blood Breaks Down” and the human interactions with leukemia patients that set the backdrop for discussions in the book.
I check in with Graham Collins (University of Oxford), David Steensma (Dana Farber Cancer Institute), and Vincent Rajkumar (Mayo Clinic) to discuss the most prevalent and noteworthy clinical research from the virtual EHA meeting discussing recent advances in Hodgkin lymphoma, MDS and AML, multiple myeloma, and DLBCL. You were unable to travel there, but you can listen to the recent
Cristiane Bergerot (@crisbergerot), PhD, health psychologist, who was at the City of Hope National Medical Center, when we taped this episode discusses when patients should be involved with a psycho-oncologist, whether the psychological state of a patient has an impact on treatment outcomes, pre-diagnosis factors that may put a patient at higher risk of depression,
Neeraj Agarwal, MD discusses management decisions for patients with advanced or metastatic prostate cancer, including weariness in using ADT for many patients with comorbidities and how clinicians are currently weighing existing regimens.
Michael Thompson, MD, PhD, Advocate Aurora Health Care, discusses social determinants of health, eligibility criteria, and other barriers to clinical trial enrollment in the community setting, as well as the importance of real-world evidence in moving the needle for oncology care. Michael has had an amazing career so far and has been serving on the
the award-winning hematologist and a medical oncologist who hosted Outspoken Oncology, a podcast featuring candid discussions of the most pressing, and often controversial, medical topics. Combining his background in cancer research and health care advocacy, Dr. Nabhan brings a unique and powerful perspective to current medical events.
